What You Need to Know Ahead of LyondellBasell’s Earnings Release
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 16 2025
0mins
Source: NASDAQ.COM
Company Overview and Earnings Expectations: LyondellBasell Industries N.V., a leading chemical company with a market cap of $24.5 billion, is set to announce its fiscal fourth-quarter earnings on January 31, 2024, with analysts predicting a profit of $0.81 per share, down from $1.26 in the previous year.
Stock Performance and Analyst Ratings: LYB shares have fallen 19.4% over the past year, underperforming compared to the S&P 500's gains, and analysts maintain a skeptical outlook with an overall "Hold" rating, while the average price target suggests a potential upside of 15.7%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LYB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LYB
Wall Street analysts forecast LYB stock price to fall
15 Analyst Rating
1 Buy
11 Hold
3 Sell
Hold
Current: 67.300
Low
36.00
Averages
47.29
High
57.00
Current: 67.300
Low
36.00
Averages
47.29
High
57.00
About LYB
LyondellBasell Industries N.V. is an independent chemical company creating solutions for everyday sustainable living. The Company's segments include Olefins and Polyolefins-Americas (O&P-Americas), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), and Technology. The O&P-Americas segment produces and markets olefins and co-products, polyethylene, and polypropylene. The I&D segment produces and markets propylene oxide (PO) and its derivatives, oxyfuels and related products, and intermediate chemicals, such as styrene monomer (SM), and acetyls. The APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, and colors. The Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Positive Revisions Trend in Q1 Earnings Reports
- Earnings Revision Trend: Zacks Director of Research Sheraz Mian highlights that despite a modest decline in Q2 earnings estimates, the overall revision trend remains positive, indicating market confidence in future profitability.
- Sector Performance Disparity: Since early April, sectors such as Energy, Tech, Basic Materials, Industrials, Utilities, and Business Services have seen upward revisions in earnings estimates, particularly in Energy and Tech, reflecting optimistic sentiment in these areas.
- Outstanding Individual Stocks: For instance, Dow (DOW) and LyondellBasell (LYB) have seen their Q2 EPS estimates double over the past month, while Methanex (MEOH) has increased by over 30%, showcasing strong performance in the current market environment.
- Negative Pressure Sectors: In contrast, sectors like Transportation, Autos, Medical, and Consumer Discretionary are facing renewed pressure on Q2 estimates, suggesting a cautious outlook that could impact stock performance in these areas.
See More
Positive Earnings Outlook for Q2 2026
- Strong Earnings Outlook: The overall earnings picture continues to improve, with positive revisions for Q2 2026 indicating enhanced market confidence, even as recent estimates have slightly declined, reflecting a resilient economic backdrop.
- Sector Performance Divergence: Since early April, sectors such as Energy, Tech, Basic Materials, Industrials, Utilities, and Business Services have seen upward revisions, particularly in Energy and Tech, highlighting a robust recovery in these areas.
- Notable Individual Stocks: EPS estimates for Dow (DOW) and LyondellBasell (LYB) have more than doubled in the past month, while Methanex (MEOH) has seen an increase of over 30%, indicating significant improvements in their earnings capabilities.
- Negative Pressure Emerging: Despite strong performances in certain sectors, Q2 estimates for Transportation, Autos, Medical, and Consumer Discretionary have faced renewed pressure since the beginning of the period, indicating ongoing market divergence and uncertainty.
See More
Positive Earnings Outlook for Q2 2026
- Strong Earnings Outlook: The overall earnings picture continues to improve, with positive revisions for Q2 2026 expectations indicating enhanced market confidence, even though recent estimates have slightly declined, reflecting a resilient economic backdrop.
- Sector Performance Divergence: Since early April, sectors such as Energy, Tech, Basic Materials, Industrials, Utilities, and Business Services have seen upward revisions in earnings expectations, particularly driven by the strong recovery potential in Energy and Tech sectors.
- Notable Stock Performance: Q2 EPS estimates for Dow (DOW) and LyondellBasell (LYB) have more than doubled in the past month, while Methanex (MEOH) has seen an increase of over 30%, showcasing robust performance amid current market conditions.
- Negative Pressure Emerging: Despite strong performances in certain sectors, Q2 estimates for Transportation, Autos, Medical, and Consumer Discretionary have come under renewed pressure since the start of the period, indicating market imbalances and potential risks.
See More
Key Wall Street Ratings Updates for Thursday
- Tesla Robotaxi Expansion: Morgan Stanley reiterates Tesla as equal weight, noting survey checks indicate increased hiring of 'AI Safety Operators' in northern metro areas, suggesting Tesla is gearing up for robotaxi operations expansion, which could enhance future revenues.
- National Health Properties Outlook: Citizens initiates coverage of National Health Properties as outperform, believing the REIT is enhancing organic growth by increasing exposure to Senior Housing Operating Properties, indicating confidence in the senior living market.
- Nvidia Data Center Potential: Bernstein reiterates Nvidia as outperform, highlighting the enormous and still early datacenter opportunity, which is expected to provide significant upside, reflecting optimism in tech stocks.
- Quanta Services Rating Upgrade: Oppenheimer upgrades Quanta Services from perform to outperform with an $800 price target, indicating strong growth potential in the coming years, particularly in adjusted EBITDA expectations.
See More
Updated Quant Ratings for Large-Cap Materials Companies Post Earnings Season
- Quant Rating Overview: As earnings season concludes, investors are shifting their focus to updated quant ratings based on the latest corporate results, which reflect how companies are positioned across key factors such as valuation, growth, profitability, momentum, and earnings revisions.
- Top-Rated Companies: Among large-cap materials companies with market capitalizations above $10 billion, Glencore (GLNCY) leads with a quant rating of 4.90, indicating a strong buy signal, followed closely by LyondellBasell (LYB) and Lynas Rare Earths (LYSDY) with ratings of 4.89 and 4.87, respectively, also signaling strong buy.
- Bottom-Rated Companies: Conversely, Avery Dennison (AVY) has the lowest quant rating at 1.80, indicating a sell signal, with Heidelberg Materials (HDLMY) and Akzo Nobel (AKZOY) also underperforming with ratings of 1.81 and 1.87.
- Market Impact Analysis: The shifts in these quant ratings not only reflect the strengths and weaknesses of the companies' fundamentals but may also influence investor decisions, particularly in shaping investment strategies within the materials sector, prompting investors to monitor these dynamic ratings closely to optimize their portfolios.
See More
Four High-Growth GARP Stocks for 2026
- DaVita's Growth Potential: DaVita, a leading provider of dialysis services in the U.S., demonstrated strong momentum in Q1 2026 with an impressive long-term growth rate of 20.2%, making it an ideal GARP investment choice due to its reasonable PEG and P/E ratios, showcasing sustainable profitability.
- Integra's Market Demand: Integra LifeSciences leads in regenerative medicine, with a projected five-year growth rate of 5.9% for 2026, as steady demand in neurosurgery and ENT products highlights the company's strong competitive position in the medical device market.
- Braskem's Industry Position: Braskem manufactures petrochemical products in Brazil and internationally, with an expected long-term growth rate of 16.8%, and its superior value and growth scores make it stand out in GARP investment strategies, reflecting robust performance in the global market.
- LyondellBasell's Historical Growth: LyondellBasell holds a significant position in the global plastics and chemicals industry, boasting a historical growth rate of 49.4%, and its reasonable PEG and P/E ratios position it as a preferred choice for GARP investors, demonstrating strong market potential.
See More
Positive Revisions Trend in Q1 Earnings Reports
- Earnings Revision Trend: Zacks Director of Research Sheraz Mian highlights that despite a modest decline in Q2 earnings estimates, the overall revision trend remains positive, indicating market confidence in future profitability.
- Sector Performance Disparity: Since early April, sectors such as Energy, Tech, Basic Materials, Industrials, Utilities, and Business Services have seen upward revisions in earnings estimates, particularly in Energy and Tech, reflecting optimistic sentiment in these areas.
- Outstanding Individual Stocks: For instance, Dow (DOW) and LyondellBasell (LYB) have seen their Q2 EPS estimates double over the past month, while Methanex (MEOH) has increased by over 30%, showcasing strong performance in the current market environment.
- Negative Pressure Sectors: In contrast, sectors like Transportation, Autos, Medical, and Consumer Discretionary are facing renewed pressure on Q2 estimates, suggesting a cautious outlook that could impact stock performance in these areas.
See More
Positive Earnings Outlook for Q2 2026
- Strong Earnings Outlook: The overall earnings picture continues to improve, with positive revisions for Q2 2026 indicating enhanced market confidence, even as recent estimates have slightly declined, reflecting a resilient economic backdrop.
- Sector Performance Divergence: Since early April, sectors such as Energy, Tech, Basic Materials, Industrials, Utilities, and Business Services have seen upward revisions, particularly in Energy and Tech, highlighting a robust recovery in these areas.
- Notable Individual Stocks: EPS estimates for Dow (DOW) and LyondellBasell (LYB) have more than doubled in the past month, while Methanex (MEOH) has seen an increase of over 30%, indicating significant improvements in their earnings capabilities.
- Negative Pressure Emerging: Despite strong performances in certain sectors, Q2 estimates for Transportation, Autos, Medical, and Consumer Discretionary have faced renewed pressure since the beginning of the period, indicating ongoing market divergence and uncertainty.
See More
Positive Earnings Outlook for Q2 2026
- Strong Earnings Outlook: The overall earnings picture continues to improve, with positive revisions for Q2 2026 expectations indicating enhanced market confidence, even though recent estimates have slightly declined, reflecting a resilient economic backdrop.
- Sector Performance Divergence: Since early April, sectors such as Energy, Tech, Basic Materials, Industrials, Utilities, and Business Services have seen upward revisions in earnings expectations, particularly driven by the strong recovery potential in Energy and Tech sectors.
- Notable Stock Performance: Q2 EPS estimates for Dow (DOW) and LyondellBasell (LYB) have more than doubled in the past month, while Methanex (MEOH) has seen an increase of over 30%, showcasing robust performance amid current market conditions.
- Negative Pressure Emerging: Despite strong performances in certain sectors, Q2 estimates for Transportation, Autos, Medical, and Consumer Discretionary have come under renewed pressure since the start of the period, indicating market imbalances and potential risks.
See More
Key Wall Street Ratings Updates for Thursday
- Tesla Robotaxi Expansion: Morgan Stanley reiterates Tesla as equal weight, noting survey checks indicate increased hiring of 'AI Safety Operators' in northern metro areas, suggesting Tesla is gearing up for robotaxi operations expansion, which could enhance future revenues.
- National Health Properties Outlook: Citizens initiates coverage of National Health Properties as outperform, believing the REIT is enhancing organic growth by increasing exposure to Senior Housing Operating Properties, indicating confidence in the senior living market.
- Nvidia Data Center Potential: Bernstein reiterates Nvidia as outperform, highlighting the enormous and still early datacenter opportunity, which is expected to provide significant upside, reflecting optimism in tech stocks.
- Quanta Services Rating Upgrade: Oppenheimer upgrades Quanta Services from perform to outperform with an $800 price target, indicating strong growth potential in the coming years, particularly in adjusted EBITDA expectations.
See More
Updated Quant Ratings for Large-Cap Materials Companies Post Earnings Season
- Quant Rating Overview: As earnings season concludes, investors are shifting their focus to updated quant ratings based on the latest corporate results, which reflect how companies are positioned across key factors such as valuation, growth, profitability, momentum, and earnings revisions.
- Top-Rated Companies: Among large-cap materials companies with market capitalizations above $10 billion, Glencore (GLNCY) leads with a quant rating of 4.90, indicating a strong buy signal, followed closely by LyondellBasell (LYB) and Lynas Rare Earths (LYSDY) with ratings of 4.89 and 4.87, respectively, also signaling strong buy.
- Bottom-Rated Companies: Conversely, Avery Dennison (AVY) has the lowest quant rating at 1.80, indicating a sell signal, with Heidelberg Materials (HDLMY) and Akzo Nobel (AKZOY) also underperforming with ratings of 1.81 and 1.87.
- Market Impact Analysis: The shifts in these quant ratings not only reflect the strengths and weaknesses of the companies' fundamentals but may also influence investor decisions, particularly in shaping investment strategies within the materials sector, prompting investors to monitor these dynamic ratings closely to optimize their portfolios.
See More
Four High-Growth GARP Stocks for 2026
- DaVita's Growth Potential: DaVita, a leading provider of dialysis services in the U.S., demonstrated strong momentum in Q1 2026 with an impressive long-term growth rate of 20.2%, making it an ideal GARP investment choice due to its reasonable PEG and P/E ratios, showcasing sustainable profitability.
- Integra's Market Demand: Integra LifeSciences leads in regenerative medicine, with a projected five-year growth rate of 5.9% for 2026, as steady demand in neurosurgery and ENT products highlights the company's strong competitive position in the medical device market.
- Braskem's Industry Position: Braskem manufactures petrochemical products in Brazil and internationally, with an expected long-term growth rate of 16.8%, and its superior value and growth scores make it stand out in GARP investment strategies, reflecting robust performance in the global market.
- LyondellBasell's Historical Growth: LyondellBasell holds a significant position in the global plastics and chemicals industry, boasting a historical growth rate of 49.4%, and its reasonable PEG and P/E ratios position it as a preferred choice for GARP investors, demonstrating strong market potential.
See More
